Comparison of serum and urinary concentrations of clenbuterol with and without concomitant administration of furosemide in horses.

This study examines how the combined use of two drugs, furosemide and clenbuterol, affects the circulation of clenbuterol in horses’ bodies. Researchers observed that when these drugs were given together, the amount of clenbuterol in the horses’ urine increased and the amount in their bloodstream decreased.

Objective of the Research

• The study seeks to investigate how the simultaneous use of furosemide and clenbuterol, two drugs commonly used in racehorses, affects the pharmacokinetics or movement of clenbuterol within the horse’s body.

Context and Background

• Furosemide is often administered to horses to control or prevent exercise-induced pulmonary hemorrhage, a condition where blood leaks into the horse’s lungs during high-intensity exercise like racing.
• Clenbuterol, a bronchodilator, is also regularly given to racehorses for the treatment of inflammatory airway disease.
• Despite their common usage, the interaction of these two drugs within the horse’s system has not been extensively studied before.

Methodology

• The researchers evaluated the impact of furosemide on the serum (blood) and urine concentrations of clenbuterol. The assessment was conducted after horses were orally given clenbuterol and intravenously administered furosemide.

Findings

• The study revealed that administering both furosemide and clenbuterol to horses led to increased concentrations of clenbuterol in the urine.
• Conversely, the serum or blood concentrations of clenbuterol decreased when the two drugs were used together.
• This effect was consistent throughout the study period and varied from horse to horse.

Implications

• The results of this study provide important insights into the pharmacokinetics of these two popularly used drugs, raising the possibility of varying their administration to optimally manage health conditions in racehorses.
• Additionally, the variation in effects between individual horses indicates a level of unpredictability in the response to these drugs, warranting further personalized approaches in their use.